Petros Pharmaceuticals, Inc. SEC filings PTPI
Petros Pharmaceuticals, Inc. has 257 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (bankruptcy, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bankruptcy, Officer or director change
|
Sep 30, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2026 | Jun 5, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2026 | Jan 1, 2026 |
| 25-NSE | Delisting notice | Nov 20, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 7, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Auditor change
|
Sep 5, 2025 | Aug 29, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Listing notice
|
May 21, 2025 | May 20, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change
|
May 2, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Apr 11, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 9, 2025 | Apr 5, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Mar 18, 2025 | Apr 10, 2025 |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| CORRESP | Letter to the SEC | Mar 14, 2025 | — |
| PRER14A | Filing | Mar 14, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2025 | — |
| PRE 14A | Preliminary proxy statement | Mar 7, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 21, 2025 | Feb 17, 2025 |
| 424B4 | Prospectus | Feb 19, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| S-1MEF | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| S-1/A | Amended registration statement | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 13, 2025 | — |
| S-1/A | Amended registration statement | Feb 13, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Feb 11, 2025 | — |
| S-1/A | Amended registration statement | Feb 10, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2025 | — |
| S-1 | Registration statement | Jan 24, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Jan 24, 2025 | Jan 23, 2025 |
| 8-K | Current report | Dec 16, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 21, 2024 | Nov 20, 2024 |
| DEFA14A | Additional proxy material | Nov 18, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Oct 25, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Oct 25, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Oct 17, 2024 | Oct 11, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 15, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2024 | Oct 1, 2024 |
| 8-K | Current report | Sep 19, 2024 | Sep 16, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-K/A | Amended annual report | May 31, 2024 | Dec 31, 2023 |
| EFFECT | Filing | May 20, 2024 | — |
| CORRESP | Letter to the SEC | May 17, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| UPLOAD | Letter from the SEC | May 9, 2024 | — |
| S-3 | Shelf registration | May 3, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 22, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Auditor change
|
Jan 12, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 29, 2023 | Dec 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 28, 2023 | Dec 21, 2023 |
| ARS | Annual report to shareholders | Nov 30, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Nov 30, 2023 | Dec 29, 2023 |
| 10-Q | Quarterly report | Nov 15, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Nov 15, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 2, 2023 | Sep 29, 2023 |
| 424B3 | Prospectus | Sep 19, 2023 | — |
| EFFECT | Filing | Sep 18, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| S-3/A | Form s-3/a | Sep 15, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Sep 15, 2023 | Sep 14, 2023 |
| DEF 14A | Proxy statement | Aug 25, 2023 | Sep 14, 2023 |
| UPLOAD | Letter from the SEC | Aug 16, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 15, 2023 | Aug 15, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2023 | Sep 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| S-3 | Shelf registration | Aug 11, 2023 | — |
| D | Filing | Jul 21, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jul 13, 2023 | Jul 13, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| S-8 | Employee stock plan registration | Dec 22, 2022 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Nov 30, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2022 | Nov 15, 2022 |
| 10-Q/A | Amended quarterly report | Nov 15, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| EFFECT | Filing | Oct 20, 2022 | — |
| POS AM | Filing | Oct 14, 2022 | — |
| DEFA14A | Additional proxy material | Oct 12, 2022 | — |
| DEF 14A | Proxy statement | Oct 12, 2022 | Nov 29, 2022 |
| PRE 14A | Preliminary proxy statement | Sep 30, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Other events
|
Jul 28, 2022 | Jul 28, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 24, 2022 | Jun 22, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
Apr 26, 2022 | Apr 26, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 4, 2022 | Apr 1, 2022 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Apr 1, 2022 | Dec 22, 2021 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 24, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 21, 2022 | Jan 18, 2022 |
| EFFECT | Filing | Jan 14, 2022 | — |
| 424B3 | Prospectus | Jan 14, 2022 | — |
| CORRESP | Letter to the SEC | Jan 12, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2022 | — |
| CORRESP | Letter to the SEC | Jan 12, 2022 | — |
| S-1 | Registration statement | Jan 6, 2022 | — |
| D | Filing | Jan 3, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 27, 2021 | Dec 22, 2021 |
| 424B5 | Prospectus supplement | Dec 23, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 23, 2021 | Dec 22, 2021 |
| 424B3 | Prospectus | Dec 20, 2021 | — |
| EFFECT | Filing | Dec 17, 2021 | — |
| CORRESP | Letter to the SEC | Dec 15, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2021 | — |
| S-1 | Registration statement | Dec 13, 2021 | — |
| D | Filing | Dec 3, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 1, 2021 | Nov 29, 2021 |
| 424B5 | Prospectus supplement | Dec 1, 2021 | — |
| EFFECT | Filing | Nov 23, 2021 | — |
| 424B3 | Prospectus | Nov 23, 2021 | — |
| CORRESP | Letter to the SEC | Nov 23, 2021 | — |
| DEF 14A | Proxy statement | Nov 22, 2021 | Dec 22, 2021 |
| CORRESP | Letter to the SEC | Nov 22, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| 8-K | Current report | Nov 17, 2021 | Nov 17, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| S-1 | Registration statement | Nov 12, 2021 | — |
| D | Filing | Oct 26, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 15, 2021 | Oct 13, 2021 |
| 424B5 | Prospectus supplement | Oct 15, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement
|
Apr 6, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2021 | Feb 19, 2021 |
| EFFECT | Filing | Feb 4, 2021 | — |
| CORRESP | Letter to the SEC | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2021 | — |
| S-3 | Shelf registration | Jan 29, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2021 | Jan 19, 2021 |
| S-8 | Employee stock plan registration | Jan 22, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 19, 2021 | Jan 19, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 31, 2020 | Dec 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 10, 2020 | Dec 7, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 2, 2020 | Dec 1, 2020 |
| 8-A12B | Filing | Dec 1, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 3, 2020 | — |
| 424B3 | Prospectus | Nov 2, 2020 | — |
| EFFECT | Filing | Oct 29, 2020 | — |
| S-4/A | Filing | Oct 28, 2020 | — |
| CORRESP | Letter to the SEC | Oct 27, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 22, 2020 | — |
| S-4/A | Filing | Oct 21, 2020 | — |
| CORRESP | Letter to the SEC | Oct 15, 2020 | — |
| S-4/A | Filing | Oct 15, 2020 | — |
| CORRESP | Letter to the SEC | Sep 30, 2020 | — |
| S-4/A | Filing | Sep 30, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2020 | — |
| S-4 | Registration for a merger or exchange | Jul 24, 2020 | — |
Showing 170 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTPI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1815903
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.